Related Tags >> Intermezzo Novacea Purdue Pharma insomnia

Transcept Pharmaceuticals News

Most Popular Transcept Pharmaceuticals Story

Purdue, Transcept ink $145M commercialization deal

August 4, 2009 — 6:06am ET | By Maureen Martino

Purdue Pharmaceutical and Transcept Pharmaceuticals have signed a deal to commercialize the sleep aid Intermezzo. Purdue gains the rights to market, sell and distribute Intermezzo in the United Read more...

Transcept Pharmaceuticals Press Releases

Transcept Pharmaceuticals Receives $10 Million Milestone Payment from Purdue for Listing of Intermezzo Formulation Patents
Transcept Pharmaceuticals Announces Intermezzo® PDUFA Action Date Of November 27, 2011
Transcept Pharmaceuticals Announces Plan to Resubmit Intermezzo® New Drug Application Following Meeting with the FDA
Transcept Pharmaceuticals Resubmits Intermezzo® New Drug Application for the Treatment of Middle of the Night Awakenings
Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo(R) Highway Driving Study

Latest Headlines

Transcept Pharma battles to get FDA nod for sleep drug
November 23, 2011
Transcept shares soar (again) on quick review deadline for Intermezzo
October 4, 2011
Transcept shares soar on revived NDA hopes for Intermezzo
September 15, 2011
Transcept Pharma faces more hurdles to gain approval of sleep drug
July 15, 2011
Transcept Pharma expects bad news on insomnia drug from FDA
July 13, 2011
Transcept readies second attempt at sleep drug approval
October 19, 2010
Transcept shares battered after FDA denies Intermezzo OK
October 29, 2009
Transcept's development success spurs a 30% layoff
August 18, 2009
Purdue, Transcept ink $145M commercialization deal
August 4, 2009
Novacea dumps Asentar, focuses on merger
September 12, 2008
Novacea inks takeover agreement with Transcept
September 2, 2008

Paid Research Reports

More Research Reports >>

Free Newsletter

Most Popular Stories

Webinars

Hottest Products

Featured Jobs

Events